Inicio > Medicina > Medicina clínica e interna > Enfermedades y trastornos > Oncología > Making the Case for MTET
Making the Case for MTET

Making the Case for MTET

Mohammad A Nezami

305,84 €
IVA incluido
Disponible
Editorial:
Cancer Research and Life Foundation
Año de edición:
2024
Materia
Oncología
ISBN:
9798986347264
305,84 €
IVA incluido
Disponible

Selecciona una librería:

  • Librería Desdémona
  • Librería Samer Atenea
  • Librería Aciertas (Toledo)
  • Kálamo Books
  • Librería Perelló (Valencia)
  • Librería Elías (Asturias)
  • Donde los libros
  • Librería Kolima (Madrid)
  • Librería Proteo (Málaga)
Sobre IBD

Millions of cancer cases are diagnosed yearly. While a cure has yet to be discovered, one of the most promising new treatments is Multi-Targeted Epigenetic Therapy, or MTET.In Making the Case for MTET, world-renowned oncology expert Dr. Mohammad A. Nezami introduces his revolutionary method of treating patients with advanced cancer by using a careful combination of drugs and genomic sequencing. For some patients with stage four cancer, MTET has been a lifesaving intervention.  Dr. Nezami presents 300 case studies of patients with advanced cancer that he treated over ten years of longitudinal tracking with MTET. Through meticulously documented data, lab reports, and full-color photographs to detailed genomic information, Dr. Nezami makes a compelling case for furthering MTET research and focusing on patient-centric care.

Artículos relacionados

  • Pancreatic Cancer
    Born Incredible
    'Pancreatic Cancer: A Comprehensive Resource for Patients and Families' is an essential guide for anyone affected by this challenging disease. This meticulously crafted book offers an in-depth look into the world of pancreatic cancer, providing valuable insights and support for patients, their families, and caregivers.Structured into a number of thoughtfully organized chapters,...
  • Liver Cancer
    Ethan D. Anderson
    Navigate the complexities of liver cancer with 'Liver Cancer: A Comprehensive Resource for Patients and Families.' This essential guide is a beacon of knowledge, empathy, and support, offering in-depth insights into every aspect of liver cancer, from understanding the disease to managing life during and after treatment.Understanding Liver CancerThe book begins with a foundation...
  • Endometrial Cancer
    Ethan D. Anderson
    Step into a world of understanding and support with 'Endometrial Cancer: A Comprehensive Resource for Patients and Families.' This book is a vital companion for anyone touched by endometrial cancer, offering deep insights and guidance through every stage of the journey, from diagnosis to survivorship.Understanding the DiseaseThe book begins by demystifying endometrial cancer, d...
  • Cervical Cancer
    Ethan D. Anderson
    Navigate the complexities of cervical cancer with the definitive guide, 'Cervical Cancer: A Comprehensive Resource for Patients and Families.' This book is an essential ally for those facing the diagnosis, providing clarity and support every step of the way.Understanding the BasicsBegin with a clear, concise introduction to cervical cancer, including types, prevalence, and the ...
  • Smart Business Problems and Analytical Hints in Cancer Research
    Zemelak Goraga
    'Smart Business Problems and Analytical Hints in Cancer Research' is a pioneering exploration of the intersection between data science, artificial intelligence, machine learning, and oncology. Delving into 25 advanced questions derived from real-world cancer research scenarios, this book offers comprehensive guidelines on leveraging data-driven methodologies to address key chal...
    Disponible

    39,71 €

  • Molecular Analysis of LTFR and YAP Genes in Breast Cancer Patients
    Real Sumayya Abdul Sattar
    Breast cancer accounts for 25% of the world cancers and is the most frequent cancer among women. Less developed regions had 883,000 breast cancer cases whereas more developed regions had 794,000 breast cancer cases. It is second most prevalent cancer and ranks fifth with respect to overall cancer related mortality, with a prediction of increase in new cases upto 22 million in t...